KLSE (MYR): ALPHA (0303)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.315
Today's Change
0.00 (0.00%)
Day's Change
0.315 - 0.32
Trading Volume
1,509,300
Exchange: Bursa Malaysia Bursa Malaysia
Country Code: MY MY
Currency: MYR MYR
Sector: HEALTH CARE HEALTH CARE
Subsector: HEALTH CARE PROVIDERS HEALTH CARE PROVIDERS
so hard to push up even with those volume, at least alpha is building up the momentum
3 weeks ago
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3514931
I followed Dr. Lee and bought at 33.5 cents
3 weeks ago
only half sen? dream higher la, I wish their business is good so we can get more dividend
2 weeks ago
still havent meet the criteria also, earliest also 2026 only can transfer to main board
2 weeks ago
Dr. Lee bought again. Strong support will be formed at 32 cents
https://klse.i3investor.com/web/insider/detail/D_183655_946568881
1 week ago
Indeed, excellent Q2 performance = good news. Feel free to peruse it 😊
https://klse.i3investor.com/web/blog/detail/NewLifeNewWay/2025-01-22-story-h497934750-Alpha_IVF_Reports_Yet_Another_Record_Q2_FY25_Financial_Results
1 week ago
Alpha IVF Group’s 2QFY5/25 net profit increased 23.6% YoY to RM15.1m thanks to higher sales revenue from foreign patients. Indonesian patients are Alpha IVF’s largest clientele, contributing about 34.9% to its total revenue while patients from China contributed 25.2%. Beyond China, Alpha IVF further expanded in the Southeast Asia region with the establishment of a full-fledged IVF centre in the Philippines and a first satellite clinic in Indonesia, tapping into these rapidly growing markets.
Sadly no dividend announced
1 week ago
Higher sales figures are mostly from foreign patients, good move for Alpha to keep expanding towards China and South East Asia.
1 week ago
Patients dr Indonesia paling byk. Rasa bilangan patient dr Filipina dan Cina juga akan bertmbah scr berdadah pd masa depan
1 week ago
it is undervalued indeed, even analyst forecast that the industry will continue to see decent growth yet the price of the share is not moving at all
1 week ago
The next few quarters should continue to see decent growth, on the back of increased patient volume from China following the launch of the sales representative office
https://www.thestar.com.my/business/business-news/2025/01/23/alpha-ivf-to-see-rising-customer-demand
5 days ago
Alpha said that 2Q25 continued to see a high foreign patient mix, in part due to maiden contribution from the SRO in Shanghai, China. A full quarter’s contribution from the China SRO and the establishment of a satellite clinic in Jakarta, Indonesia should support overall patient volume
5 days ago
even uob still maintaining their buy recommendation, means the current price really below its real value
5 days ago
Short term will get down to 28...it has broken 32 support. No other catalyst until next QR
4 days ago
I dnt think so because there will be another market expansion and it will rebound
1 day ago
Hopefully. Only time will tell. Recent Q earnings did not even move the stock by any means....
1 day ago
ryoyagod
The buying volume is strong, and the momentum is positive. Just wait for the imminent surge!
3 weeks ago